|
|
Volumn 62, Issue 7, 2013, Pages 653-657
|
|
Therapeutic potential of targeting inflammation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CYTOKINE ANTIBODY;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 17;
INTERLEUKIN 4;
PROSTAGLANDIN E2;
TANEZUMAB;
TRANSCRIPTOME;
ARTHRITIS;
ATHEROSCLEROSIS;
AUTOIMMUNITY;
BODY TEMPERATURE;
CELL TRANSPLANTATION;
CHRONIC INFLAMMATION;
CHRONIC PAIN;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
DEGENERATIVE DISEASE;
DISEASE SEVERITY;
EPIGENETICS;
HOMEOSTASIS;
HUMAN;
IMMUNOGENICITY;
IMMUNOLOGICAL TOLERANCE;
INNATE IMMUNITY;
LEUKOCYTE COUNT;
METABOLIC DISORDER;
METABOLIC STRESS;
MULTIPLE SCLEROSIS;
NEOPLASM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
OSTEOARTHRITIS;
PATHOGENESIS;
PNEUMONIA;
PROTEIN TARGETING;
PSORIASIS;
TRANSLATIONAL RESEARCH;
AUTOIMMUNE DISEASES;
CYTOKINES;
HUMANS;
INFLAMMATION;
LEUKOCYTES;
|
|
EID: 84879196220
PISSN: 10233830
EISSN: 1420908X
Source Type: Journal
DOI: 10.1007/s00011-013-0614-3 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
